First characterization of the CD4 and CD8 T-cell responses to QuantiFERON-TB Plus

Journal of Infection

Volumn 73, Issue 6, 2016, Pages 588-597

  Petruccioli, Elisa ^a   Chiacchio, Teresa ^a   Pepponi, Ilaria ^a   Vanini, Valentina ^a   Urso, Rocco ^a   Cuzzi, Gilda ^a   Barcellini, Lucia ^b   Cirillo, Daniela Maria ^b   Palmieri, Fabrizio ^a   Ippolito, Giuseppe ^a   Goletti, Delia ^a  

^a NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Active TB; CD4; CD8; LTBI; QuantiFERON TB Plus; Tuberculosis

Indexed keywords

BACTERIAL ANTIGEN; GAMMA INTERFERON; DIAGNOSTIC KIT;

ADULT; ANTIGEN SPECIFICITY; ARTICLE; BACTERIAL LOAD; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; FEMALE; FLOW CYTOMETRY; HUMAN; LATENT TUBERCULOSIS; LUNG TUBERCULOSIS; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS TEST KIT; NONHUMAN; PATIENT CODING; RECENT LATENT TUBERCULOSIS; REMOTE LATENT TUBERCULOSIS; THORAX RADIOGRAPHY; DIAGNOSTIC IMAGING; DIAGNOSTIC KIT; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOLOGY; MICROBIOLOGY; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; PROCEDURES; TUBERCULOSIS;

ADULT; ANTIGENS, BACTERIAL; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMANS; INTERFERON-GAMMA; LATENT TUBERCULOSIS; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; REAGENT KITS, DIAGNOSTIC; TUBERCULOSIS;

EID: 85006277096     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2016.09.008     Document Type: Article

References (44)

1. 1 WHO, Global tuberculosis report 2015. WHO global TB report 2015, 20th ed., 2015 http://apps.who.int/iris/bitstream/10665/191102/1/9789241565059_eng.pdf?ua=1.
2. 2 Trauer, J.M., Moyo, N., Tay, E.L., Dale, K., Ragonnet, R., McBryde, E.S., et al. Risk of active tuberculosis in the five years following infection… 15%?. Chest 149:2 (2016 Feb), 516–525.
3. 3 Rangaka, M.X., Wilkinson, K.A., Glynn, J.R., Ling, D., Menzies, D., Mwansa-Kambafwile, J., et al. Predictive value of interferon-gamma release assays for incident active tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis 12:1 (2012 Jan), 45–55.
4. 4 Lonnroth, K., Migliori, G.B., Abubakar, I., D'Ambrosio, L., de Vries, G., Diel, R., et al. Towards tuberculosis elimination: an action framework for low-incidence countries. Eur Respir J 45:4 (2015 Apr), 928–952.
5. 5 Goletti, D., Sanduzzi, A., Delogu, G., Performance of the tuberculin skin test and interferon-gamma release assays: an update on the accuracy, cutoff stratification, and new potential immune-based approaches. J Rheumatol Suppl 91 (2014 May), 24–31.
6. 6 Getahun, H., Gunneberg, C., Granich, R., Nunn, P., HIV infection-associated tuberculosis: the epidemiology and the response. Clin Infect Dis 50:Suppl. 3 (2010 May 15), S201–S207.
7. 7 Getahun, H., Matteelli, A., Abubakar, I., Aziz, M.A., Baddeley, A., Barreira, D., et al. Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries. Eur Respir J 46:6 (2015 Dec), 1563–1576.
8. 8 Santin, M., Munoz, L., Rigau, D., Interferon-gamma release assays for the diagnosis of tuberculosis and tuberculosis infection in HIV-infected adults: a systematic review and meta-analysis. PLoS One, 7(3), 2012, e32482.
9. 9 Vincenti, D., Carrara, S., Butera, O., Bizzoni, F., Casetti, R., Girardi, E., et al. Response to region of difference 1 (RD1) epitopes in human immunodeficiency virus (HIV)-infected individuals enrolled with suspected active tuberculosis: a pilot study. Clin Exp Immunol 150:1 (2007 Oct), 91–98.
10. 10 Sester, M., Sotgiu, G., Lange, C., Giehl, C., Girardi, E., Migliori, G.B., et al. Interferon-gamma release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis. Eur Respir J 37:1 (2011 Jan), 100–111.
11. 11 Sester, M., van Leth, F., Bruchfeld, J., Bumbacea, D., Cirillo, D.M., Dilektasli, A.G., et al. Risk assessment of tuberculosis in immunocompromised patients. A TBNET study. Am J Respir Crit Care Med 190:10 (2014 Nov 15), 1168–1176.
12. 12 Day, C.L., Abrahams, D.A., Lerumo, L., Janse van Rensburg, E., Stone, L., O'rie, T., et al. Functional capacity of Mycobacterium tuberculosis-specific T cell responses in humans is associated with mycobacterial load. J Immunol 187:5 (2011 Sep 1), 2222–2232.
13. 13 Day, C.L., Moshi, N.D., Abrahams, D.A., van Rooyen, M., O'rie, T., de Kock, M., et al. Patients with tuberculosis disease have Mycobacterium tuberculosis-specific CD8 T cells with a pro-apoptotic phenotype and impaired proliferative capacity, which is not restored following treatment. PLoS One, 9(4), 2014 Apr 16, e94949.
14. 14 Chiacchio, T., Petruccioli, E., Vanini, V., Cuzzi, G., Pinnetti, C., Sampaolesi, A., et al. Polyfunctional T-cells and effector memory phenotype are associated with active TB in HIV-infected patients. J Infect 69:6 (2014 Dec), 533–545.
15. 15 Rozot, V., Vigano, S., Mazza-Stalder, J., Idrizi, E., Day, C.L., Perreau, M., et al. Mycobacterium tuberculosis-specific CD8+ T cells are functionally and phenotypically different between latent infection and active disease. Eur J Immunol 43:6 (2013 Jun), 1568–1577.
16. 16 Nikolova, M., Markova, R., Drenska, R., Muhtarova, M., Todorova, Y., Dimitrov, V., et al. Antigen-specific CD4- and CD8-positive signatures in different phases of Mycobacterium tuberculosis infection. Diagn Microbiol Infect Dis 75:3 (2013 Mar), 277–281.
17. 17 Lancioni, C., Nyendak, M., Kiguli, S., Zalwango, S., Mori, T., Mayanja-Kizza, H., et al. CD8+ T cells provide an immunologic signature of tuberculosis in young children. Am J Respir Crit Care Med 185:2 (2012 Jan 15), 206–212.
18. 18 Lewinsohn, D.M., Tydeman, I.S., Frieder, M., Grotzke, J.E., Lines, R.A., Ahmed, S., et al. High resolution radiographic and fine immunologic definition of TB disease progression in the rhesus macaque. Microbes Infect 8:11 (2006 Sep), 2587–2598.
19. 19 Billeskov, R., Vingsbo-Lundberg, C., Andersen, P., Dietrich, J., Induction of CD8 T cells against a novel epitope in TB10.4: correlation with mycobacterial virulence and the presence of a functional region of difference-1. J Immunol 179:6 (2007 Sep 15), 3973–3981.
20. 20 Kamath, A., Woodworth, J.S., Behar, S.M., Antigen-specific CD8+ T cells and the development of central memory during Mycobacterium tuberculosis infection. J Immunol 177:9 (2006 Nov 1), 6361–6369.
21. 21 Nyendak, M.R., Park, B., Null, M.D., Baseke, J., Swarbrick, G., Mayanja-Kizza, H., et al. Mycobacterium tuberculosis specific CD8(+) T cells rapidly decline with antituberculosis treatment. PLoS One, 8(12), 2013 Dec 4, e81564.
22. 22 Losi, M., Knights, A.J., Mariani, F., Altieri, A.M., Paone, G., Loxton, A.G., et al. QuantiFERON-TB performance enhanced by novel Mycobacterium tuberculosis-specific antigens. Eur Respir J 47:2 (2016 Feb), 660–664.
23. 23 Barcellini, L., Borroni, E., Brown, J., Brunetti, E., Codecasa, L., Cugnata, F., et al. First independent evaluation of QuantiFERON-TB Plus performance. Eur Respir J 47:5 (2016 Feb 11), 1587–1590.
24. 24 Barcellini, L., Borroni, E., Brown, J., Brunetti, E., Campisi, D., Castellotti, P.F., et al. First evaluation of QuantiFERON-TB Gold Plus performance in contact screening. Eur Respir J, 2016 Jul 7, 10.1183/13993003.00510-2016 pii: ERJ-00510-2016 [Epub ahead of print].
25. 25 Cirillo, D.M., Barcellini, L., Goletti, D., Preliminary data on precision of QuantiFERON-TB Plus performance. Eur Respir J 48:3 (2016 Sep), 955–956.
26. 26 Gallagher, D., Manissero, D., Stocking, C., Pyne, C., Preliminary data on precision of QuantiFERON-TB Plus performance. Eur Respir J 48:3 (2016 Sep), 953–954.
27. 27 Yi, L., Sasaki, Y., Nagai, H., Ishikawa, S., Takamori, M., Sakashita, K., et al. Evaluation of QuantiFERON-TB gold plus for detection of Mycobacterium tuberculosis infection in Japan. Sci Rep, 6, 2016 Jul 29, 30617.
28. 28 Hoffmann, H., Avsar, K., Gores, R., Mavi, S.C., Hofmann-Thiel, S., Equal sensitivity of the new generation QuantiFERON-TB Gold plus in direct comparison with the previous test version QuantiFERON-TB Gold IT. Clin Microbiol Infect 22:8 (2016 Aug), 701–703.
29. ®-TB Gold Plus, ELISA Package Insert, QUIAGEN. http://www.quantiferon.com/irm/content/PI/QFT/PLUS/2PK-Elisa/UK.pdf.
30. 30 Goletti, D., Butera, O., Vanini, V., Lauria, F.N., Lange, C., Franken, K.L., et al. Response to Rv2628 latency antigen associates with cured tuberculosis and remote infection. Eur Respir J 36:1 (2010 Jul), 135–142.
31. 31 Delogu, G., Chiacchio, T., Vanini, V., Butera, O., Cuzzi, G., Bua, A., et al. Methylated HBHA produced in M. smegmatis discriminates between active and non-active tuberculosis disease among RD1-responders. PLoS One, 6(3), 2011 Mar 29, e18315.
32. 32 Vanini, V., Petruccioli, E., Gioia, C., Cuzzi, G., Orchi, N., Rianda, A., et al. IP-10 is an additional marker for tuberculosis (TB) detection in HIV-infected persons in a low-TB endemic country. J Infect 65:1 (2012 Jul), 49–59.
33. 33 Ralph, A.P., Ardian, M., Wiguna, A., Maguire, G.P., Becker, N.G., Drogumuller, G., et al. A simple, valid, numerical score for grading chest X-ray severity in adult smear-positive pulmonary tuberculosis. Thorax 65:10 (2010 Oct), 863–869.
34. 34 Petruccioli, E., Petrone, L., Vanini, V., Cuzzi, G., Navarra, A., Gualano, G., et al. Assessment of CD27 expression as a tool for active and latent tuberculosis diagnosis. J Infect 71:5 (2015 Nov), 526–533.
35. 35 Petruccioli, E., Petrone, L., Vanini, V., Sampaolesi, A., Gualano, G., Girardi, E., et al. IFNgamma/TNFalpha specific-cells and effector memory phenotype associate with active tuberculosis. J Infect 66:6 (2013 Jun), 475–486.
36. 36 Petruccioli, E., Navarra, A., Petrone, L., Vanini, V., Cuzzi, G., Gualano, G., et al. Use of several immunological markers to model the probability of active tuberculosis. Diagn Microbiol Infect Dis 86:2 (2016 Oct), 169–171.
37. 37 Goletti, D., Petruccioli, E., Joosten, S.A., Ottenhoff, T.H., Tuberculosis biomarkers: from diagnosis to protection. Infect Dis Rep, 8(2), 2016 Jun 24, 6568.
38. 38 Lewinsohn, D.A., Heinzel, A.S., Gardner, J.M., Zhu, L., Alderson, M.R., Lewinsohn, D.M., Mycobacterium tuberculosis-specific CD8+ T cells preferentially recognize heavily infected cells. Am J Respir Crit Care Med 168:11 (2003 Dec 1), 1346–1352.
39. 39 Gold, M.C., Cerri, S., Smyk-Pearson, S., Cansler, M.E., Vogt, T.M., Delepine, J., et al. Human mucosal associated invariant T cells detect bacterially infected cells. PLoS Biol, 8(6), 2010 Jun 29, e1000407.
40. 40 van Pinxteren, L.A., Cassidy, J.P., Smedegaard, B.H., Agger, E.M., Andersen, P., Control of latent Mycobacterium tuberculosis infection is dependent on CD8 T cells. Eur J Immunol 30:12 (2000 Dec), 3689–3698.
41. 41 Stenger, S., Hanson, D.A., Teitelbaum, R., Dewan, P., Niazi, K.R., Froelich, C.J., et al. An antimicrobial activity of cytolytic T cells mediated by granulysin. Science 282:5386 (1998 Oct 2), 121–125.
42. 42 Barry, C.E. 3rd, Boshoff, H.I., Dartois, V., Dick, T., Ehrt, S., Flynn, J., et al. The spectrum of latent tuberculosis: rethinking the biology and intervention strategies. Nat Rev Microbiol 7:12 (2009 Dec), 845–855.
43. 43 Cho, S., Mehra, V., Thoma-Uszynski, S., Stenger, S., Serbina, N., Mazzaccaro, R.J., et al. Antimicrobial activity of MHC class I-restricted CD8+ T cells in human tuberculosis. Proc Natl Acad Sci USA 97:22 (2000 Oct 24), 12210–12215.
44. 44 Rozot, V., Patrizia, A., Vigano, S., Mazza-Stalder, J., Idrizi, E., Day, C.L., et al. Combined use of Mycobacterium tuberculosis-specific CD4 and CD8 T-cell responses is a powerful diagnostic tool of active tuberculosis. Clin Infect Dis 60:3 (2015 Feb 1), 432–437.